AI is transforming cancer research by enabling the analysis of vast amounts of data. Deep learning algorithms can identify patterns in genomic data, imaging, and clinical records, leading to the discovery of new biomarkers and potential drug targets. AI-powered platforms also assist in the design and optimization of clinical trials, making them more efficient and cost-effective.
